Changes in Opioid Prescriptions and Potential Misuse and SUDs Following 2016 Opioid Guidelines

Sep 16, 2022
1 min read

Changes in Opioid Prescriptions and Potential Misuse and Substance Use Disorders Among Childhood Cancer Survivors Following the 2016 Opioid Prescribing Guideline, in JAMA Oncology

key takeaway: "The rates of opioid prescriptions and potential misuse/substance use disorders declined significantly among both survivors and peers without cancer following the March 2016 guideline release, with survivors experiencing greater reductions."

Recent Posts

See All

Mental Health of Youths Who Use Puberty Blockers

Mental Health of Youths Who Use Puberty Blockers, in JAMA Network Open key takeaway: "prescription of a puberty blocker was associated with decreased adjusted odds of mood disorder and suicidal though

Availability of Naloxone in Retail Pharmacies Following Introduction of Over-the-Counter Status

Availability of Naloxone in Retail Pharmacies Following Introduction of Over-the-Counter Status, in JAMA Network Open key takeaway: "61.4% of pharmacies reported same-day naloxone availability without

A Decade of Innovations and Insights from FDA’s “The Real Cost” Campaigns and Youth Prevention Efforts

A Decade of Innovations and Insights from FDA’s “The Real Cost” Campaigns and Youth Prevention Efforts, special issue of American Journal of Preventive Medicine key takeaway, from the conclusion artic

PROMOTING BEHAVIORAL HEALTH TEAM

A Committee of the Partnership for a Healthier Fairfax

Changes in Opioid Prescriptions and Potential Misuse and SUDs Following 2016 Opioid Guidelines

Recent Posts

Comments